“…Moreover, adiponectin also has a direct effect on the vascular system to exert vasodilator actions, and increased blood flow. Adiponectin increases NO production through two mechanisms, namely, by activation of endothelial nitric oxide synthase (eNOS) enzyme activity and via an increase in eNOS expression in endothelial cells 37,38) . Thus, decreased adiponectin levels cause vascular dysfunction in the presence of inflammatory and oxidative vascular injuries, and enhance the predisposition to renal dysfunction.…”